Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • AcelRx management update

    AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX), Redwood City, Calif. Business: Neurology, Drug delivery Departing: Richard King as president and CEO

    Published on 11/17/2014
  • Actavis management update

    Actavis plc (NYSE:ACT), Dublin, Ireland Business: Generics, Genitourinary Hired: Maria Teresa Hilado as CFO, effective Dec. 8, formerly SVP of finance and treasurer at PepsiCo Inc.; she succeeds R. Todd Joyce

    Published on 11/17/2014
  • Alchemia management update

    Alchemia Ltd. (ASX:ACL), Brisbane, Australia Business: Chemistry, Cancer, Hematology Departed: Thomas Liquard as CEO

    Published on 11/17/2014
  • Atterocor management update

    Atterocor Inc., Ann Arbor, Mich. Business: Cancer Hired: Pharis Mohideen as CMO, formerly VP of clinical development at Shionogi & Co. Ltd.'s Shionogi Inc. U.S. company

    Published on 11/17/2014
  • Celtaxsys Inc. management update

    Celtaxsys Inc., Atlanta, Ga. Business: Pulmonary Hired: Sanjeev Ahuja as CMO, formerly CMO of On Target Laboratories LLC

    Published on 11/17/2014
  • Cubist management update

    Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Business: Infectious Promoted: Patrick Vink to EVP and COO from SVP and general manager of Cubist's international business, effective Jan. 1, 2015; he succeeds…

    Published on 11/17/2014
  • Horizon Pharma management update

    Horizon Pharma plc (NASDAQ:HZNP), Dublin, Ireland Business: Autoimmune, Inflammation, Neurology Hired: John Kody as EVP and chief commercial officer, effective Nov. 24, formerly president at Danaher's Corp.'s Leica …

    Published on 11/17/2014
  • Insulet management update

    Insulet Corp. (NASDAQ:PODD), Bedford, Mass. Business: Drug delivery, Endocrine/Metabolic Hired: Brad Thomas as EVP of human resources and organizational development, a newly created position, formerly CEO of The HR …

    Published on 11/17/2014
  • MiMedx Group management update

    MiMedx Group Inc. (NASDAQ:MDXG), Marietta, Ga. Business: Musculoskeletal, Dermatology Hired: Christopher Cashman as EVP and chief commercialization officer, formerly president and CEO of Sanuwave Health Inc.

    Published on 11/17/2014
  • Mnemosyne management update

    Mnemosyne Pharmaceuticals Inc., Providence, R.I. Business: Neurology Hired: Vanessa King as president and CEO, formerly executive director of external R&D and head of external venture innovation at Amgen Inc.; she …

    Published on 11/17/2014
  • Neurotrope management update

    Neurotrope Inc. (OTCQB:NTRP), Plantation, Fla. Business: Neurology Hired: Warren Wasiewski as EVP of development and CMO, formerly VP of neurology clinical development at Alexion Pharmaceuticals Inc.; he succeeds CMO …

    Published on 11/17/2014
  • Oxis management update

    Oxis International Inc. (OTCBB:OXIS; Euronext:OXI), Beverly Hills, Calif. Business: Nutraceuticals, Autoimmune, Inflammation Hired: Steven Weldon as CFO, chief accounting officer, and a director, formerly CFO of …

    Published on 11/17/2014
  • Paratek management update

    Paratek Pharmaceuticals Inc. (NASDAQ:PRTK), Boston, Mass. Business: Infectious Hired: Adam Woodrow as chief commercial officer, formerly VP of commercial development at Pfizer Inc.

    Published on 11/17/2014
  • Retrophin management update

    Retrophin Inc. (NASDAQ:RTRX), New York, N.Y. Business: Renal, Musculoskeletal, Pulmonary Transitioned: Stephen Aselage to CEO from interim CEO

    Published on 11/17/2014
  • Sumitomo Dainippon management update

    Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Business: Pharmaceuticals Transitioned: Hiroyuki Baba to director and head of global business development, while remaining EVP of Sumitomo Dainippon's …

    Published on 11/17/2014
  • Targovax management update

    Targovax A/S, Lysaker, Norway Business: Cancer Hired: Gunnar Gardemyr as CEO, effective Jan. 12, 2015, currently a corporate advisor at Acino Holding AG, which Nordic Capital acquired

    Published on 11/17/2014
  • Ziarco board of directors update

    Ziarco Group Ltd., Canterbury, U.K. Business: Inflammation, Dermatology, Autoimmune Appointed: Johan Kordel, senior partner at Lundbeckfond Ventures; and Ed Mathers, partner at New Enterprise Associates, as chairman

    Published on 11/17/2014
  • Bind Therapeutics management update

    Bind Therapeutics Inc. (NASDAQ:BIND), Cambridge, Mass. Business: Cancer, Drug delivery Departed: Jeff Hrkach as chief technology officer, effective the end of November Hired: Hagop Youssoufian as CMO, formerly EVP of R…

    Published on 11/10/2014
  • Cardinal Health management update

    Cardinal Health Inc. (NYSE:CAH), Dublin, Ohio Business: Drug delivery, Supply/Service Transitioned: Michael Kaufmann to CFO from CEO of Cardinal Health's pharmaceutical segment; he replaces Jeffrey Henderson, who …

    Published on 11/10/2014
  • CellaVision management update

    CellaVision AB (SSE:CEVI), Lund, Sweden Business: Diagnostic Hired: Zlatko Rihter as president and CEO, effective no later than Feb. 1, 2015, currently EVP and head of global sales and marketing at Origio A/S; he …

    Published on 11/10/2014
  • Cesca Therapeutics management update

    Cesca Therapeutics Inc. (NASDAQ:KOOL), Rancho Cordova, Calif. Business: Diagnostic, Gene/Cell therapy Departed: Matthew Plavan as CEO, while remaining a director; he is succeeded by interim CEO Robin Stracey, a director

    Published on 11/10/2014
  • Discovery Laboratories management update

    Discovery Laboratories Inc. (NASDAQ:DSCO), Warrington, Pa. Business: Pulmonary Departed: Russell Clayton as SVP of R&D, effective December Transitioned: Steven Simonson to SVP and chief development officer from VP of …

    Published on 11/10/2014
  • EnteroMedics management update

    EnteroMedics Inc. (NASDAQ:ETRM), St. Paul, Minn. Business: Endocrine/Metabolic, Gastrointestinal Hired: Brad Hancock as chief commercial officer, effective Nov. 17, formerly VP of sales and marketing at Flowonix …

    Published on 11/10/2014
  • Loxo management update

    Loxo Oncology Inc. (NASDAQ:LOXO), Stamford, Conn. Business: Cancer Promoted: Jennifer Low to CMO, while remaining EVP of R&D; she succeeds acting CMO Lori Kunkel, who becomes a director Resigned: Mikel Moyer as CSO

    Published on 11/10/2014
  • Lpath management update

    Lpath Inc. (NASDAQ:LPTN), San Diego, Calif. Business: Cancer, Ophthalmic Resigned: Scott Pancoast as president, CEO, and a director; he is succeeded by interim CEO Michael Lack

    Published on 11/10/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993